A phase II trial of Thiolanox for the treatment of cystic fibrosis
Phase of Trial: Phase II
Latest Information Update: 12 Jun 2017
At a glance
- Drugs Nitric oxide (Primary)
- Indications Cystic fibrosis
- Focus Therapeutic Use
- Sponsors Novoteris
- 12 Jun 2017 New trial record
- 05 Jun 2017 According to a Novoteris media release, subjects will be recruited from five cystic fibrosis research centers (Seattle, Los Angeles, Milwaukee, Charleston and Vancouver).
- 05 Jun 2017 According to a Novoteris media release, the US FDA and Drug Administration and the Therapeutic Products Directorate of Health Canada have cleared the clinical trial application for this trial.